Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
Joint Authors
Fernández, Maribel
Gómez-Ulla, Francisco
Charlón, Pablo
Gil, María
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-10-30
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Purpose.
To show the long-term results of intravitreal ranibizumab combined with photodynamic therapy (PDT) for the treatment of polypoidal choroidal vasculopathy (PCV).
Methods.
We analyzed the progress of two patients for 36 and 58 months, respectively.
We only used PDT for the treatment in the area of the active PCV or “hot spot” evident on the indocyanine green angiography (ICGA).
The spot size was chosen so as to cover only the active neovascular lesion.
We combined intravitreal ranibizumab with PDT when PCV remained active without visible polyps in ICGA or without a response to PDT.
Conclusion.
Administration, as required, of verteporfin photodynamic therapy combined with intravitreal ranibizumab is an effective treatment for symptomatic polypoidal choroidal vasculopathy.
These data need to be confirmed in large, prospective, and controlled clinical trials which are randomized and carried out over a long period.
American Psychological Association (APA)
Fernández, Maribel& Gil, María& Gómez-Ulla, Francisco& Charlón, Pablo. 2012. Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup. Case Reports in Medicine،Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-506347
Modern Language Association (MLA)
Fernández, Maribel…[et al.]. Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup. Case Reports in Medicine No. 2012 (2012), pp.1-10.
https://search.emarefa.net/detail/BIM-506347
American Medical Association (AMA)
Fernández, Maribel& Gil, María& Gómez-Ulla, Francisco& Charlón, Pablo. Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup. Case Reports in Medicine. 2012. Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-506347
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-506347